{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T13:46:55Z","timestamp":1794232015660,"version":"4.9.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The latest international EAACI\/GA\u00b2LEN\/EuroGuiDerm\/APAAACI guideline for urticaria recommends limited laboratory testing for chronic spontaneous urticaria (CSU) and selective testing for only certain chronic inducible urticaria (CIndU) subtypes, though the rationale for these recommendations is poorly explained. This study aimed to improve the understanding of CIndU subtypes by comprehensively comparing their demographic, clinical, and laboratory characteristics with those of the better-characterized CSU.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a retrospective analysis of 567 patients (median age 41 years, 67% female) diagnosed with CSU, symptomatic dermographism (SD), cold urticaria (ColdU), cholinergic urticaria (CholU), and delayed pressure urticaria (DPU).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our findings revealed that patients with SD, ColdU, and CholU had lower levels of C-reactive protein (CRP), higher total serum immunoglobulin E (IgE) levels, and higher basophil counts compared to CSU patients. These subtypes also had distinct demographic and clinical features, such as a younger age of onset and a longer disease duration. In contrast, patients with DPU had significantly higher CRP levels and neutrophil counts compared to those with CSU.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>These findings highlight the heterogeneity among chronic urticaria subtypes, suggesting that a tailored approach to laboratory testing may be more effective. The distinct immunological and clinical features observed in CIndU subtypes suggest a need for subtype-specific diagnostic and therapeutic guidelines.<\/jats:p><\/jats:sec>","DOI":"10.3389\/falgy.2024.1487831","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T05:13:09Z","timestamp":1729141989000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Key differences between chronic inducible and spontaneous urticaria"],"prefix":"10.3389","volume":"5","author":[{"given":"Mojca","family":"Bizjak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitja","family":"Ko\u0161nik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/all.14037","article-title":"Prevalence of chronic urticaria in children and adults across the globe: systematic review with meta-analysis","volume":"75","author":"Fricke","year":"2020","journal-title":"Allergy"},{"key":"B2","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/all.15090","article-title":"The international EAACI\/GA(2)LEN\/EuroGuiDerm\/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria","volume":"77","author":"Zuberbier","year":"2022","journal-title":"Allergy"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1016\/j.jaip.2023.08.020","article-title":"Patients with chronic spontaneous urticaria who have wheals, angioedema, or both, differ demographically, clinically, and in response to treatment-results from CURE","volume":"11","author":"Buttgereit","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41572-022-00389-z","article-title":"Urticaria","volume":"8","author":"Kolkhir","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"B5","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/jdv.16947","article-title":"The chronic urticaria registry: rationale, methods and initial implementation","volume":"35","author":"Weller","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/jdv.19637","article-title":"A comparative analysis of chronic inducible urticaria in 423 patients: clinical and laboratory features and comorbid conditions","volume":"38","author":"Ornek Ozdemir","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1111\/all.12884","article-title":"The definition, diagnostic testing, and management of chronic inducible urticarias\u2014the EAACI\/GA(2) LEN\/EDF\/UNEV consensus recommendations 2016 update and revision","volume":"71","author":"Magerl","year":"2016","journal-title":"Allergy"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.jaip.2018.03.007","article-title":"How to approach chronic inducible urticaria","volume":"6","author":"Maurer","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B9","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/all.15603","article-title":"Chronic spontaneous urticaria: focus on pathophysiology to unlock treatment advances","volume":"78","author":"Kaplan","year":"2023","journal-title":"Allergy"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/j.jaip.2021.03.033","article-title":"The pathogenesis of chronic spontaneous urticaria: the role of infiltrating cells","volume":"9","author":"Gimenez-Arnau","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B11","doi-asserted-by":"publisher","first-page":"9281","DOI":"10.3390\/ijms25179281","article-title":"Autoimmune mast cell activation test as a diagnostic tool in chronic spontaneous urticaria","volume":"25","author":"Koren","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/all.14577","article-title":"A very low number of circulating basophils is predictive of a poor response to omalizumab in chronic spontaneous urticaria","volume":"76","author":"Rijavec","year":"2021","journal-title":"Allergy"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/j.jaci.2022.04.010","article-title":"Autoimmune chronic spontaneous urticaria","volume":"149","author":"Kolkhir","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000507218","article-title":"Urticaria: collegium internationale allergologicum (CIA) update 2020","volume":"181","author":"Maurer","year":"2020","journal-title":"Int Arch Allergy Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1016\/j.jaip.2023.02.022","article-title":"Chronic spontaneous urticaria: the role and relevance of autoreactivity, autoimmunity, and autoallergy","volume":"11","author":"Asero","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B16","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.alit.2023.05.003","article-title":"Chronic urticaria and the pathogenic role of mast cells","volume":"72","author":"Elieh-Ali-Komi","year":"2023","journal-title":"Allergol Int"},{"key":"B17","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/cei.13428","article-title":"Co-occurrence of IgE and IgG autoantibodies in patients with chronic spontaneous urticaria","volume":"200","author":"Asero","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s11882-024-01160-y","article-title":"New insights into chronic inducible urticaria","volume":"24","author":"Munoz","year":"2024","journal-title":"Curr Allergy Asthma Rep"},{"key":"B19","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/imr.12632","article-title":"The role and relevance of mast cells in urticaria","volume":"282","author":"Church","year":"2018","journal-title":"Immunol Rev"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1056\/NEJM198110293051808","article-title":"Idiopathic cold urticaria: in vitro demonstration of histamine release upon challenge of skin biopsies","volume":"305","author":"Kaplan","year":"1981","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/0002-9343(81)90528-3","article-title":"The pathogenic basis of urticaria and angioedema: recent advances","volume":"70","author":"Kaplan","year":"1981","journal-title":"Am J Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.jaci.2017.06.032","article-title":"Omalizumab treatment in patients with chronic inducible urticaria: a systematic review of published evidence","volume":"141","author":"Maurer","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.3390\/cells10082170","article-title":"Roles of IgE and histamine in mast cell maturation","volume":"10","author":"Tanaka","year":"2021","journal-title":"Cells"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e12117","DOI":"10.1002\/clt2.12117","article-title":"Ige and high-affinity IgE receptor in chronic inducible urticaria, pathogenic, and management relevance","volume":"12","author":"Gimenez-Arnau","year":"2022","journal-title":"Clin Transl Allergy"},{"key":"B25","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1111\/all.13352","article-title":"C-reactive protein is linked to disease activity, impact, and response to treatment in patients with chronic spontaneous urticaria","volume":"73","author":"Kolkhir","year":"2018","journal-title":"Allergy"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/cea.14538","article-title":"Lymphopenia in chronic spontaneous urticaria is linked to basopenia and eosinopenia","author":"Bizjak","year":"2024","journal-title":"Clin Exp Allergy"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e0243447","DOI":"10.1371\/journal.pone.0243447","article-title":"Neutrophil-to-lymphocyte ratio predicts early mortality in females with metastatic triple-negative breast cancer","volume":"15","author":"de la Cruz-Ku","year":"2020","journal-title":"PLoS One"},{"key":"B28","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1186\/s12879-023-08845-1","article-title":"Pooled prevalence of lymphopenia in all-cause hospitalisations and association with infection: a systematic review and meta-analysis","volume":"23","author":"Elcioglu","year":"2023","journal-title":"BMC Infect Dis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jaip.2019.08.025","article-title":"Eosinopenia, in chronic spontaneous urticaria, is associated with high disease activity, autoimmunity, and poor response to treatment","volume":"8","author":"Kolkhir","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B30","doi-asserted-by":"publisher","first-page":"4138","DOI":"10.1016\/j.jaip.2021.07.043","article-title":"Autoimmune chronic spontaneous urticaria detection with IgG anti-TPO and total IgE","volume":"9","author":"Kolkhir","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.jaci.2017.08.007","article-title":"Increased IgE levels are linked to faster relapse in patients with omalizumab-discontinued chronic spontaneous urticaria","volume":"140","author":"Ertas","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.jaip.2022.11.016","article-title":"The benefit of complete response to treatment in patients with chronic spontaneous urticaria-CURE results","volume":"11","author":"Kolkhir","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s40521-024-00366-9","article-title":"Risk of anaphylaxis associated with cold urticaria","volume":"11","author":"Bizjak","year":"2024","journal-title":"Curr Treat Options Allergy"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.jaci.2023.03.034","article-title":"The 7-day recall period version of the urticaria control test-UCT7","volume":"152","author":"Buttgereit","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1398-9995.2010.02496.x","article-title":"Unmet clinical needs in chronic spontaneous urticaria. A GA(2)LEN task force report","volume":"66","author":"Maurer","year":"2011","journal-title":"Allergy"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1111\/all.13878","article-title":"Diagnosis and treatment of chronic inducible urticaria","volume":"74","author":"Maurer","year":"2019","journal-title":"Allergy"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1111\/1346-8138.16119","article-title":"Predictive features associated with chronic spontaneous urticaria recurrence","volume":"48","author":"Toubi","year":"2021","journal-title":"J Dermatol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s12016-021-08841-w","article-title":"Differences and similarities in the mechanisms and clinical expression of bradykinin-mediated vs. mast cell-mediated angioedema","volume":"61","author":"Maurer","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1111\/all.15194","article-title":"Risk factors for systemic reactions in typical cold urticaria: results from the COLD-CE study","volume":"77","author":"Bizjak","year":"2022","journal-title":"Allergy"},{"key":"B40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/15569527.2018.1495227","article-title":"The effect of omalizumab on hematological and inflammatory parameters in patients with chronic spontaneous urticaria","volume":"38","author":"Acer","year":"2019","journal-title":"Cutan Ocul Toxicol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.jaip.2018.02.024","article-title":"Emerging biomarkers and therapeutic pipelines for chronic spontaneous urticaria","volume":"6","author":"Deza","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1016\/j.jaip.2024.04.027","article-title":"Non-skin related symptoms are common in chronic spontaneous urticaria and linked to active and uncontrolled disease: results from the chronic urticaria registry","volume":"12","author":"Pyatilova","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.3390\/biomedicines10112697","article-title":"Usefulness of complete blood count (CBC) to assess cardiovascular and metabolic diseases in clinical settings: a comprehensive literature review","volume":"10","author":"Seo","year":"2022","journal-title":"Biomedicines"},{"key":"B44","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.aller.2019.11.007","article-title":"Neutrophil-lymphocyte ratio: a possible marker of remission in children with chronic spontaneous urticaria","volume":"48","author":"Karaman","year":"2020","journal-title":"Allergol Immunopathol (Madr)"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.3906\/sag-1803-87","article-title":"Evaluation of platelet parameters and neutrophil\/lymphocyte ratio during omalizumab treatment in patients with severe chronic spontaneous urticaria","volume":"48","author":"Ertas","year":"2018","journal-title":"Turk J Med Sci"},{"key":"B46","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/15569527.2019.1684316","article-title":"How does omalizumab affect the immunoinflammatory response in patients with chronic spontaneous urticaria?","volume":"39","author":"Onder","year":"2020","journal-title":"Cutan Ocul Toxicol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.3390\/jcm12072639","article-title":"Chronic urticaria treatment with omalizumab-verification of NLR, PLR, SIRI and SII as biomarkers and predictors of treatment efficacy","volume":"12","author":"Tarkowski","year":"2023","journal-title":"J Clin Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1111\/j.1365-2222.2011.03789.x","article-title":"Plasma IL-6 concentration correlates with clinical disease activity and serum C-reactive protein concentration in chronic urticaria patients","volume":"41","author":"Kasperska-Zajac","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"B49","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/cea.12870","article-title":"Potential blood biomarkers in chronic spontaneous urticaria","volume":"47","author":"Kolkhir","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"B50","doi-asserted-by":"publisher","first-page":"11328","DOI":"10.3390\/ijms241411328","article-title":"Biomarkers for monitoring treatment response of omalizumab in patients with chronic urticaria","volume":"24","author":"Pedersen","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B51","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2147\/JAA.S184986","article-title":"Biomarkers in chronic spontaneous urticaria: current targets and clinical implications","volume":"12","author":"Puxeddu","year":"2019","journal-title":"J Asthma Allergy"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1111\/bjd.14768","article-title":"Updosing nonsedating antihistamines in patients with chronic spontaneous urticaria: a systematic review and meta-analysis","volume":"175","author":"Guillen-Aguinaga","year":"2016","journal-title":"Br J Dermatol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.autrev.2017.10.003","article-title":"Autoimmune comorbidity in chronic spontaneous urticaria: a systematic review","volume":"16","author":"Kolkhir","year":"2017","journal-title":"Autoimmun Rev"},{"key":"B54","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jid.2022.07.012","article-title":"GWAS of chronic spontaneous urticaria reveals genetic overlap with autoimmune diseases, not atopic diseases","volume":"143","author":"Zhang","year":"2023","journal-title":"J Invest Dermatol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/S0190-9622(85)70208-3","article-title":"Cold urticaria. Clinical findings in 220 patients","volume":"13","author":"Neittaanm\u00e4ki","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1111\/all.14674","article-title":"Cold urticaria\u2014what we know and what we do not know","volume":"76","author":"Maltseva","year":"2021","journal-title":"Allergy"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1111\/jdv.13765","article-title":"Atopic predisposition in cholinergic urticaria patients and its implications","volume":"30","author":"Altrichter","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"206","DOI":"10.4168\/aair.2021.13.2.206","article-title":"Total IgE as a marker for chronic spontaneous urticaria","volume":"13","author":"Altrichter","year":"2021","journal-title":"Allergy Asthma Immunol Res"}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2024.1487831\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T05:13:13Z","timestamp":1729141993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2024.1487831\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,17]]},"references-count":58,"alternative-id":["10.3389\/falgy.2024.1487831"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2024.1487831","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/falgy.2024.1487831.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/falgy.2024.1487831.s002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/falgy.2024.1487831.s003","asserted-by":"subject"}]},"ISSN":["2673-6101"],"issn-type":[{"value":"2673-6101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,17]]},"article-number":"1487831"}}